phenoxybenzamine has been researched along with Day Blindness in 2 studies
Phenoxybenzamine: An alpha-adrenergic antagonist with long duration of action. It has been used to treat hypertension and as a peripheral vasodilator.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| James, ML | 1 |
| Keifer, JC | 1 |
| Raper, AJ | 1 |
| Jessee, EF | 1 |
| Texter, JH | 1 |
| Giffler, RF | 1 |
| Hietala, TS | 1 |
2 other studies available for phenoxybenzamine and Day Blindness
| Article | Year |
|---|---|
Posterior optic nerve ischemic neuropathy in the setting of phenoxybenzamine therapy after uneventful spinal fusion.
Topics: Adrenal Gland Neoplasms; Adult; Humans; Male; Optic Nerve; Optic Neuropathy, Ischemic; Phenoxybenzam | 2011 |
Pheochromocytoma of the urinary bladder: a broad clinical spectrum.
Topics: Adult; Catecholamines; Female; Humans; Hypertension; Phenoxybenzamine; Phentolamine; Pheochromocytom | 1977 |